Celcuity shares fall as launch delay eclipses US approval for breast cancer drug - Reuters
Celcuity shares fall as launch delay eclipses US approval for breast cancer drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxNX1pJbjBWT2s0X0RCTFN5dEdyRG93Y0llSE5acllyMlhNek15SENaUjdicjlZanZWUGhlMzktUWdra1ZuVHNyZEx5eXRqUjRreURxaC1icjBKSGR6UnZqdmFoMmdiWnYtd0JoRlU3dTE3UzNmV0ZNZWtUMnJrNmJZU0dtZV9wZTM1cFlfNnZ4RUtvTnFQeWxjUjhzdVozVnkzWTl2RGJPQmRBMUlHRy1vNDNxZnM2bXU5R2V3YTZzdlZYYnJUaHUyUg?oc=5" target="_blank">Celcuity shares fall as launch delay eclipses US approval for breast cancer drug</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
US FDA approves Asahi Kasei's drug for persistent herpes infections Reuters
October 9, 2026 at 06:01 PMFour signs it is about to get uglier in the bond market as yields rise - Reuters
Four signs it is about to get uglier in the bond market as yields rise Reuters
October 9, 2026 at 04:18 PMTeva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMAI-centered US stock bull market nears four-year anniversary - Reuters
AI-centered US stock bull market nears four-year anniversary Reuters
October 9, 2026 at 11:15 AMArgenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PMIndian shares extend losses as RBI rate hike, rising oil weigh - Reuters
Indian shares extend losses as RBI rate hike, rising oil weigh Reuters
October 8, 2026 at 02:23 AM